Subscribe

Shitanshu Uppal

Checkmate 0358: Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer

Nivolumab alone or in combination with ipilimumab shows promise in recurrent or metastatic cervical cancer, with significant objective response rates and manageable safety profiles.

Publications Update # 55

Molecular testing in endometrial cancer. Checkmate 358 trial cervical cancer

Clinical Significance of Molecular Testing of Endometrial Cancer

Update on the molecular classification of endometrial cancer and its clinical significance.

Free Solo

GOG-LAP2: Laparoscopy Compared With Laparotomy for Endometrial Cancer Staging

Laparoscopic surgical staging for uterine cancer is feasible and safe, showing fewer complications and shorter hospital stays compared to laparotomy

Radiation Therapy for Definitive Treatment of Inoperable Endometrial Cancer

OV-HIPEC 1: Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

The addition of HIPEC to interval cytoreductive surgery for stage III epithelial ovarian cancer significantly improves recurrence-free and overall survival without an increase in severe side effects.

Fertility Preservation in EIN/CAH

Fertility Preservation in EIN/CAH and Grade 1/2 endometrial Cancer

Publications Update # 54

The investment answer, surrogate endpoints in oncology, GOG-279 and A18 in cervical cancer

GOG 279: Cisplatin, Gemcitabine, and IMRT for Locally Advanced Vulvar Carcinoma

Weekly Cisplatin and Gemcitabine concurrent with IMRT improved CPR in women with locally advanced vulvar squamous cell carcinoma not amenable to surgical resection.